Aug 13, 2015 at 20:35 | Source: Moneycontrol.com
Sparc Systems has informed that the Board of Directors of the Company at its meeting held on August 13, 2015, inter alia, has approved and taken note of the following items: 1. The Board of Directors have accepted resignation of Mr. Amit Bothra, as Independent Director of the Company w.e.f. July 31, 2015.
Aug 03, 2015 at 09:25 | Source: CNBC-TV18
With earnings season on, here is the list of stocks rallying on results released this week.
Aug 03, 2015 at 08:00 | Source: CNBC-TV18
Larsen and Toubro | Maruti Suzuki | Suzlon Energy | TVS Motor | Ashok Leyland | Steel Strips | Den Networks | V2 Retail | Raymond | JBF Industries | SPARC | Jet Airways | SpiceJet and PTC India Financial are stocks, which are in the news today.
Aug 01, 2015 at 13:25 | Source: Moneycontrol.com
The steep reduction in loss was due to break even at EBITDA level (earnings before interest, tax, depreciation and amortisation) against loss of Rs 9.5 crore in the corresponding quarter of last fiscal.
Aug 01, 2015 at 13:01 | Source: PTI
The product is to be manufactured at Sun Pharmaceutical Industries' Halol facility and the USFDA has indicated that a satisfactory resolution of the current good manufacturing practice (cGMP) deficiencies at this facility is a prerequisite for the final approval of Xelpros, SPARC said.
Aug 01, 2015 at 10:38 | Source: Moneycontrol.com
Latanoprost BAK-free is a Benzyalkonium Chloride-free, once-a-day formulation of the glaucoma medication Latanoprost using SPARCs novel swollen micelle microemulsion (SMM) technology.
Aug 01, 2015 at 10:27 | Source: Moneycontrol.com
Sun Pharma Advanced Research Company (SPARC) today announced that the US Food and Drug Administration (USFDA) has issued a Complete Response letter (CRL) to its New Drug Application (NDA) for Xelpros, Latanoprost BAK-free eyedrops.
Jul 30, 2015 at 22:39 | Source: PTI
India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.
Jul 14, 2015 at 11:00 | Source: Moneycontrol.com
Shares of Sun Pharmaceutical Industries slipped 1 percent intraday Tuesday after the company's active pharma ingredients plant in Ahmednagar (in Maharashtra) audited by the American drug regulator USFDA last month.
Jul 13, 2015 at 22:12 | Source: CNBC-TV18
During the audit of Sun Pharma's Active Pharma Ingredients plant in Ahmednagar by US FDA, minor compliance observations were noted, which won't impact the facility adversely.